Medical News

RSS

Henry Schein second-quarter 2010 net sales increase 15.1% to $1.8 billion

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended June 26, 2010.

2 Aug 2010

HDL does not predict heart attack risk after dramatic statin therapy: Study

People with high levels of "good cholesterol," HDL-C, tend to have fewer heart attacks, but HDL-C may offer little protection to people who take statins to lower harmful LDL cholesterol, researchers reported July 21. At Brigham and Women's Hospital in Boston, Dr. Paul Ridker and colleagues analyzed a large study of healthy people who took the statin CRESTOR® (rosuvastatin calcium) to prevent heart attacks. They found that in this group, having high HDL-C was a bad predictor of heart attack risk.

2 Aug 2010

Rethink Autism, eSchool News offer webinar to show how schools can save costs using new technology

Public school administrators are facing the prospect of deeper budget cuts in cities and states nationwide. Meanwhile, schools with fewer resources are challenged to comply with the federal Individuals with Disabilities Education Act, which guarantees "free appropriate" education to all disabled students, including the growing number of students with an Autism Spectrum Disorder. In addition, parents are pressuring schools to either comply with the IDEA or face legal action.

2 Aug 2010

K-V Pharmaceutical receives NYSE non-compliance notification

K-V Pharmaceutical Company announced today that the Company received notification from the New York Stock Exchange on July 27, 2010 of non-compliance regarding the Company's quantitative continued listing standards. The NYSE informed the Company that its Class A Common Stock equity issue has fallen below criteria for the average closing price of a NYSE security of not less than $1.00 over a consecutive 30-trading day period.

2 Aug 2010

Life Technologies launches new assay to detect deadly strain of E. coli

Life Technologies, a provider of innovative life science solutions, announced at the International Association of Food Protection annual meeting the launch of the MicroSEQ E. coli O157:H7 assay, designed to detect the deadly strain of Escherichia coli (E. coli), using the company's industry-leading real-time PCR technology.

2 Aug 2010

DAIICHI SANKYO EUROPE adopts DATATRAK's eClinical platform for cardiovascular clinical study

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that DAIICHI SANKYO EUROPE GmbH has selected DATATRAK's eClinical™ platform for a cardiovascular clinical study encompassing 80 sites and 1,200 patients across Europe.

2 Aug 2010

Trimega Laboratories CEO shortlisted for 'Entrepreneur of the Year' in National Business Awards

Avi Lasarow, CEO of Trimega Laboratories, has been shortlisted for 'Entrepreneur of the Year' in the National Business Awards for the second year running.

2 Aug 2010

LifePoint Hospitals second-quarter revenues up 7.5% to $790.6 million

LifePoint Hospitals, Inc. today announced results for the second quarter and six months ended June 30, 2010.

2 Aug 2010

Charles River Laboratories International second-quarter 2010 net sales decline 5.2%

Charles River Laboratories International, Inc. today reported its results for the second quarter of 2010. For the quarter, net sales were $292.1 million, a decline of 5.2% from $308.2 million in the second quarter of 2009. Foreign currency translation reduced the sales growth rate by 0.1%. A modest sales increase in the Research Models and Services segment was offset by lower sales for the Preclinical Services segment.

2 Aug 2010

First Edition: August 2, 2010

Today's headlines include news about a pre-recess Senate push to pass a state aid measure as well as a preview of a White House report to be issued today that predicts savings in the Medicare program.

2 Aug 2010

IRIS International closes AlliedPath acquisition

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that it has closed the acquisition of AlliedPath, Inc., a private, early stage high complexity, CLIA-certified laboratory focused on oncology and molecular diagnostics.

2 Aug 2010

Healthsouth Corporation experiences positive trends in second quarter

HealthSouth Corporation, the nation's largest provider of inpatient rehabilitative healthcare services, today reported its results of operations for the quarter ended June 30, 2010. "The positive trends we experienced in the first quarter of 2010 continued into the second quarter as good volume growth, solid pricing, and disciplined expense management resulted in growth in all key, financial metrics," said Jay Grinney, President and Chief Executive Officer of HealthSouth.

2 Aug 2010

INEOS agrees to sell Global Films business to Bilcare AG

INEOS Group has today entered into a binding agreement for the sale of its Global Films business to Bilcare AG, one of the world's leading providers of research led packaging to the global pharmaceuticals industry, for approximately EUR100 million. The agreement brings together complimentary capabilities and synergy's of two leading global businesses.

2 Aug 2010

Singapore Ministry of Health awards Accenture with contract to implement NEHR system

The Singapore Ministry of Health has awarded Accenture, a contract to implement the National Electronic Health Record (NEHR) system, a key enabler of Singapore's vision toward a national, integrated health care system. The NEHR is designed to improve the quality of healthcare for citizens, lower the costs of health services, and promote more effective health policies.

2 Aug 2010

Research shows no link between CCSVI and development of multiple sclerosis

Two important new studies challenge the controversial hypothesis that venous congestion—chronic cerebrospinal venous insufficiency (CCSVI)—contributes to the development of multiple sclerosis (MS). This theory has resulted in many MS patients receiving experimental endovascular angioplasty, a treatment for MS unproven by clinical trials.

2 Aug 2010

Humana second quarter consolidated revenues rises 10% to $8.65 billion

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended June 30, 2010 (2Q10) of $2.00, above management's guidance of $1.65 to $1.70. The 2Q10 results compared to EPS of $1.67 for the quarter ended June 30, 2009 (2Q09). For the six months ended June 30, 2010 (1H10) the company reported $3.52 in EPS compared to $2.89 for the six months ended June 30, 2009 (1H09).

2 Aug 2010

Researchers discover mechanism linking H. pylori infection and stomach cancer

Researchers have discovered a mechanism by which Helicobacter pylori, the only known cancer-causing bacterium, disables a tumor suppressor protein in host cells.The new study, in the journal Oncogene, reports the discovery of a previously unknown mechanism linking H. pylori infection and stomach cancer, the second leading cause of cancer deaths worldwide.

2 Aug 2010

Lexicon acquires equity shares of Symphony Icon Holdings

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today announced that it has exercised a restructured purchase option under its drug development financing collaboration with Symphony Icon Holdings LLC and acquired all the equity of Symphony Icon, Inc., thereby reacquiring all rights to LX1031, LX1032, LX1033 and the other drug programs subject to the collaboration.

2 Aug 2010

DR Walk-in Medical Center at Union Square for quality health care

A new way to receive affordable, quality health care arrives in lower Manhattan today, as the physicians of New York Walk In Medical Group, PC, open a DR Walk-in Medical Center in the new Duane Reade at 1 Union Square.

2 Aug 2010

Inpatient rehab helps patient to regain functions lost from injury, illness

After a person receives acute care in a "regular" hospital for catastrophic illness, traumatic injury or a debilitating chronic condition, the next step in the process of recovery often involves a stay at an inpatient rehabilitation, or rehab, facility.Patients often have little warning when they're quickly moved to a rehab facility from acute care. Those who envision a long, leisurely recovery in a hospital or at home may find that the abrupt transition-and new responsibilities in rehab-leaves their heads spinning.

2 Aug 2010